Endovascular Management of Pelvic Congestion Syndrome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Endovascular embolization.
- Who it may be relevant to
- Registry conditions: Pelvic Congestion Syndrome. Basic parameters: 17 years — 55 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Role of Endovascular Management of Pelvic Congestion Syndome
Overview
Pelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms and improving quality of life in women diagnosed with PCS
Detailed description
Pelvic congestion syndrome is characterized by chronic pelvic pain resulting from pelvic venous reflux and varicosities. Endovascular embolization has emerged as a minimally invasive treatment with promising clinical outcomes. This prospective interventional study will evaluate the efficacy and safety of endovascular embolization in female patients with clinically suspected and imaging-confirmed PCS. Patients will undergo clinical assessment, imaging evaluation, and endovascular treatment according to standard institutional protocols. Clinical outcomes will be assessed using pain scores and symptom improvement during follow-up, while procedural success, technical outcomes, and complications will also be recorded
Interventions
- Procedure Endovascular embolization
Transcatheter embolization of incompetent ovarian and/or pelvic veins using standard embolic materials according to institutional practice to treat pelvic congestion syndrome.
Primary outcome measures
- Improvement in pelvic pain after endovascular embolization [Time frame: 6 months]
Secondary outcome measures (4)
- Technical success of embolization [Time frame: during the procedure]
- Change in quality of life [Time frame: 6 months]
- Procedure-related complications [Time frame: up to 30 days after the procedure]
- Quality of life improvement [Time frame: 6 months]
Eligibility criteria
Inclusion criteria
- Female patients aged 18 years or older.
- Chronic pelvic pain for more than 6 months.
- Clinical suspicion of pelvic congestion syndrome.
- Imaging findings consistent with pelvic congestion syndrome on Doppler ultrasound, CT venography, MR venography, or catheter venography.
- Patients willing to undergo endovascular embolization.
- Written informed consent obtained
Exclusion criteria
- Pregnancy.
- Active pelvic inflammatory disease.
- Known pelvic malignancy.
- Chronic pelvic pain due to other identifiable causes (e.g., endometriosis, large uterine fibroids).
- Contraindication to iodinated contrast media.
- Severe renal impairment.
- Uncorrectable coagulation disorders.
- Refusal to participate.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Interventional radiology unit, Sohag university hospital — Sohag
Identifiers
NCT: NCT07735156 · SUH-PCS-2026-01